Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.
| CEO: |
Peter John Harrison |
| CFO: |
Bruce Hiscock |
| Chairman: |
Ian James Nicholson |
| Independent Non-Executive Director: |
Nicholas (Nick) John McCooke, Joanne (Jo) Pisani |
| Address: |
27-28 Eastcastle Street, London, United Kingdom |
| Phone: |
|
| Fax: |
|
| Website: |
http://www.bioventix.com |
| Email: |
|